Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brief Exposure to Hyperoxia After Chronic Spinal Cord Injury
NCT05467215Phase 1Recruiting
- Sponsor
- University of Alberta
- Start
- Jul 2022
- Primary completion
- Dec 2026
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxygen in spinal cord injury (SCI) (2 arms), sponsored by University of Alberta. Primary endpoint: Skin Sensation. Started Jul 2022; status: recruiting.
02
Drugs
oxygen
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT05467215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05467215.